loadpatents
Patent applications and USPTO patent grants for Olson; William C..The latest application filed is for "psma antibody-drug conjugates".
Patent | Date |
---|---|
Psma Antibody-drug Conjugates App 20210023094 - Ma; Dangshe ;   et al. | 2021-01-28 |
Methods For Reducing Viral Load In Hiv-1 Infected Patients App 20200306372 - Olson; William C. ;   et al. | 2020-10-01 |
Methods for reducing viral load in HIV-1 infected patients Grant 10,500,274 - Olson , et al. Dec | 2019-12-10 |
PSMA antibodies and uses thereof Grant 9,695,248 - Maddon , et al. July 4, 2 | 2017-07-04 |
Anti-PRLR antibodies and methods for killing PRLR-expressing cells Grant 9,545,451 - Papadopoulos , et al. January 17, 2 | 2017-01-17 |
Methods for killing PSMA-expressing, taxane-resistant cancer cells Grant 9,242,012 - Ma , et al. January 26, 2 | 2016-01-26 |
Psma Antibodies And Uses Thereof App 20150197577 - Maddon; Paul J. ;   et al. | 2015-07-16 |
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20150175681 - Ma; Dangshe ;   et al. | 2015-06-25 |
Biomarkers For Psma Targeted Therapy For Prostate Cancer App 20150147339 - OLSON; WILLIAM C. ;   et al. | 2015-05-28 |
Combination Therapies With Psma Ligand Conjugates App 20150110814 - Olson; William C. ;   et al. | 2015-04-23 |
Antibodies for the treatment of Clostridium difficile-associated infection and disease Grant 8,986,697 - Ma , et al. March 24, 2 | 2015-03-24 |
Anti-prlr Antibodies And Uses Thereof App 20150056222 - PAPADOPOULOS; Nicholas J. ;   et al. | 2015-02-26 |
Methods For Inhibiting Hiv-1 Replication Involving The Administration Of An Anti-ccr5 Receptor Monoclonal Antibody And Small Molecule Ccr5 Receptor Antagonist App 20140377259 - Olson; William C. ;   et al. | 2014-12-25 |
Psma Antibodies And Uses Thereof App 20140286859 - Maddon; Paul J. ;   et al. | 2014-09-25 |
Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist Grant 8,821,877 - Olson , et al. September 2, 2 | 2014-09-02 |
Methods For Reducing Viral Load In Hiv-1 Infected Patients App 20130216526 - Olson; William C. ;   et al. | 2013-08-22 |
Method For Preventing Hiv-1 Infection Of Cd4+ Cells App 20130211043 - Allaway; Graham P. ;   et al. | 2013-08-15 |
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20130202618 - Ma; Dangshe ;   et al. | 2013-08-08 |
PSMA antibodies and uses thereof Grant 8,470,330 - Maddon , et al. June 25, 2 | 2013-06-25 |
Compositions of PSMA antibodies Grant 8,114,965 - Maddon , et al. February 14, 2 | 2012-02-14 |
Methods For Killing Psma-expressing, Taxane-resistant Cancer Cells App 20110250216 - Ma; Dangshe ;   et al. | 2011-10-13 |
Modified Gp140 Envelope Polypeptides Of Hiv-1 Isolates, Compositions, Stabilized Trimeric Complexes, And Uses Thereof App 20110250220 - Dey; Antu K. ;   et al. | 2011-10-13 |
Methods For Reducing Viral Load in HIV-1 Infected Patients App 20110200592 - OLSON; WILLIAM C. ;   et al. | 2011-08-18 |
Psma Antibodies And Uses Thereof App 20110165081 - Schulke; Norbert ;   et al. | 2011-07-07 |
Methods Of Inhibiting Infection By Diverse Subtypes Of Drug-resistant Hiv-1 App 20110135634 - Olson; William C. | 2011-06-09 |
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain Grant 7,939,083 - Dey , et al. May 10, 2 | 2011-05-10 |
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Grant 7,935,797 - Allaway , et al. May 3, 2 | 2011-05-03 |
Soluble stabilized trimeric hiv env proteins and uses thereof App 20110076298 - Olson; William C. ;   et al. | 2011-03-31 |
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Grant 7,858,298 - Allaway , et al. December 28, 2 | 2010-12-28 |
PSMA antibodies and protein multimers Grant 7,850,971 - Maddon , et al. December 14, 2 | 2010-12-14 |
Anti-CCR5 antibody Grant 7,851,600 - Olson , et al. December 14, 2 | 2010-12-14 |
Methods for reducing viral load in HIV-1 infected patients App 20100178290 - Olson; William C. ;   et al. | 2010-07-15 |
Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors Grant 7,736,649 - Olson , et al. June 15, 2 | 2010-06-15 |
Liquid Injector For Silicon Production App 20100103765 - HORNBOSTEL; MARC D. ;   et al. | 2010-04-29 |
Anti-CCR5 antibody Grant 7,666,419 - Olson , et al. February 23, 2 | 2010-02-23 |
Modified Gp140 Envelope Polypeptides Of Hiv-1 Isolates, Compositions, Stabilized Trimeric Coplexes, And Uses Thereof App 20100041875 - Dey; Antu K. ;   et al. | 2010-02-18 |
Stabilized viral envelope proteins and uses thereof Grant 7,592,014 - Binley , et al. September 22, 2 | 2009-09-22 |
Methods of inhibiting HIV-2 infection App 20090074766 - Ketas; Thomas J. ;   et al. | 2009-03-19 |
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins Grant 7,479,553 - Binley , et al. January 20, 2 | 2009-01-20 |
Compositions of PSMA antibodies App 20080286284 - Maddon; Paul J. ;   et al. | 2008-11-20 |
Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex App 20080274134 - Schulke; Norbert ;   et al. | 2008-11-06 |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,446,177 - Olson , et al. November 4, 2 | 2008-11-04 |
Methods for reducing viral load in HIV-1-infected patients App 20080241135 - Olson; William C. ;   et al. | 2008-10-02 |
Method for preventing HIV-1 infection of CD4 cells App 20080187539 - Allaway; Graham P. ;   et al. | 2008-08-07 |
Method for preventing HIV-1 infection of CD4+ Cells App 20080138897 - Allaway; Graham P. ;   et al. | 2008-06-12 |
Anti-CCR5 antibody App 20080107595 - Olson; William C. ;   et al. | 2008-05-08 |
Nucleic acids encoding polypeptides of anti-CCR5 antibodies App 20080015348 - Olson; William C. ;   et al. | 2008-01-17 |
Compositions comprising anti-CCR5 antibody App 20070274986 - Olson; William C. ;   et al. | 2007-11-29 |
Anti-CCR5 antibodies App 20070231327 - Olson; William C. ;   et al. | 2007-10-04 |
PSMA antibody-drug conjugates App 20070160617 - Ma; Dangshe ;   et al. | 2007-07-12 |
Anti-CCR5 antibody App 20070031408 - Olson; William C. ;   et al. | 2007-02-08 |
Methods for reducing viral load in HIV-1-infected patients App 20070026441 - Olson; William C. ;   et al. | 2007-02-01 |
Compositions and methods for inhibition of HIV-1 infection App 20070020280 - Olson; William C. ;   et al. | 2007-01-25 |
L-SIGN polymorphisms and methods involving use of same App 20060292151 - Gardner; Jason P. ;   et al. | 2006-12-28 |
Compositions and methods for inhibition of HIV-1 infection Grant 7,138,119 - Olson , et al. November 21, 2 | 2006-11-21 |
Methods for inhibiting HIV-1 infection App 20060233798 - Olson; William C. ;   et al. | 2006-10-19 |
Anti-CCR5 antibody Grant 7,122,185 - Olson , et al. October 17, 2 | 2006-10-17 |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20060198855 - Olson; William C. ;   et al. | 2006-09-07 |
Methods for inhibiting HIV-1 infection Grant 7,060,273 - Olson , et al. June 13, 2 | 2006-06-13 |
Stabilized viral envelope proteins and uses thereof App 20060094049 - Binley; James M. ;   et al. | 2006-05-04 |
Stabilized viral envelope proteins and uses thereof Grant 7,022,324 - Binley , et al. April 4, 2 | 2006-04-04 |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,022,323 - Olson , et al. April 4, 2 | 2006-04-04 |
Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods App 20060051373 - Olson; William C. ;   et al. | 2006-03-09 |
Method for preventing HIV-1 infection of CD4+ cells App 20060029932 - Allaway; Graham P. ;   et al. | 2006-02-09 |
CD4-IgG2 formulations App 20050276798 - Olson, William C. ;   et al. | 2005-12-15 |
PSMA formulations and uses thereof App 20050215472 - Schulke, Norbert ;   et al. | 2005-09-29 |
CD4-IgG2 formulations App 20050142139 - Schulke, Norbert ;   et al. | 2005-06-30 |
Sulfated CCR5 peptides for HIV-1 infection Grant 6,908,734 - Dragic , et al. June 21, 2 | 2005-06-21 |
Human immunodeficiency virus envelope clycoprotein mutants and uses thereof App 20050089526 - Moore, John P. ;   et al. | 2005-04-28 |
Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto App 20040228869 - Olson, William C. ;   et al. | 2004-11-18 |
Stabilized viral envelope proteins and uses thereof App 20040224308 - Binley, James M. ;   et al. | 2004-11-11 |
PSMA formulations and uses thereof App 20040161776 - Maddon, Paul J. ;   et al. | 2004-08-19 |
Anti-cd19 immunotoxins App 20040136908 - Olson, William C. ;   et al. | 2004-07-15 |
Compositions and methods for inhibition of HIV-1 infection App 20040062767 - Olson, William C. ;   et al. | 2004-04-01 |
Stabilized viral envelope proteins and uses thereof Grant 6,710,173 - Binley , et al. March 23, 2 | 2004-03-23 |
PSMA antibodies and protein multimers App 20040033229 - Maddon, Paul J. ;   et al. | 2004-02-19 |
Compositions and methods for inhibition of HIV-1 infection Grant 6,692,745 - Olson , et al. February 17, 2 | 2004-02-17 |
Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection App 20030232745 - Olson, William C. ;   et al. | 2003-12-18 |
Anti-CCR5 antibody App 20030228306 - Olson, William C. ;   et al. | 2003-12-11 |
CD4-IgG2-based salvage therapy of HIV-1 infection App 20030211470 - Olson, William C. ;   et al. | 2003-11-13 |
Sulfated CCR5 peptides for HIV-1 infection App 20030139571 - Dragic, Tatjana ;   et al. | 2003-07-24 |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20030134297 - Olson, William C. ;   et al. | 2003-07-17 |
Sulfated CCR5 peptides for HIV-1 infection App 20030092632 - Dragic, Tatjana ;   et al. | 2003-05-15 |
Compositions and methods for inhibition of hiv-1 infection App 20030082185 - Olson, William C. ;   et al. | 2003-05-01 |
Sulfated CCR5 peptides for HIV-1 infection Grant 6,548,636 - Dragic , et al. April 15, 2 | 2003-04-15 |
Stabilized viral envelope proteins and uses thereof App 20030052839 - Binley, James M. ;   et al. | 2003-03-20 |
Methods for inhibiting HIV-1 infection App 20030044411 - Olson, William C. ;   et al. | 2003-03-06 |
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20030013081 - Olson, William C. ;   et al. | 2003-01-16 |
Method for preventing HIV-1 infection of CD4+ cells App 20020155429 - Allaway, Graham P. ;   et al. | 2002-10-24 |
Methods for inhibiting HIV-1 infection App 20020146415 - Olson, William C. ;   et al. | 2002-10-10 |
Compositions and methods for inhibition of HIV-1 infection App 20020106374 - Olson, William C. ;   et al. | 2002-08-08 |
Sulfated CCR5 peptides for HIV-1 infection App 20020068813 - Dragic, Tatjana ;   et al. | 2002-06-06 |
Method for preventing HIV-1 infection of CD4+ cells Grant 6,344,545 - Allaway , et al. February 5, 2 | 2002-02-05 |
Method for preventing HIV-1 infection of CD4.sup.+ cells Grant 6,107,019 - Allaway , et al. August 22, 2 | 2000-08-22 |
SEC | 0001327414 | Olson William C |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.